New therapeutics for the treatment of glycosphingolipid lysosomal storage diseases.
Glycosphingolipid lysosomal storage diseases are a small but challenging group of human disorders to treat. Although these appear to be monogenic disorders where the catalytic activity of enzymes in glycosphingolipid catabolism is impaired, the presentation and severity of disease is heterogeneous....
मुख्य लेखकों: | Butters, T, Dwek, R, Platt, F |
---|---|
स्वरूप: | Journal article |
भाषा: | English |
प्रकाशित: |
2003
|
समान संसाधन
-
Glycosphingolipid lysosomal storage diseases: therapy and pathogenesis.
द्वारा: Jeyakumar, M, और अन्य
प्रकाशित: (2002) -
Inhibition of glycosphingolipid biosynthesis: application to lysosomal storage disorders.
द्वारा: Butters, T, और अन्य
प्रकाशित: (2000) -
Substrate deprivation: a new therapeutic approach for the glycosphingolipid lysosomal storage diseases.
द्वारा: Platt, F, और अन्य
प्रकाशित: (2000) -
New developments in treating glycosphingolipid storage diseases.
द्वारा: Platt, F, और अन्य
प्रकाशित: (2005) -
Glycosphingolipid profiling of tissues from mouse models of human lysosomal storage disorders
द्वारा: Priestman, D, और अन्य
प्रकाशित: (2008)